ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,885,000 | +1150.9% | 870,000 | +1540.2% | 0.28% | +762.5% |
| Q2 2020 | $1,110,000 | -95.3% | 53,043 | -96.8% | 0.03% | -95.7% |
| Q1 2020 | $23,399,000 | -52.5% | 1,677,367 | -22.5% | 0.74% | -52.7% |
| Q4 2019 | $49,263,000 | +138.4% | 2,164,471 | +22.0% | 1.57% | +86.5% |
| Q3 2019 | $20,666,000 | +21.2% | 1,773,938 | +56.0% | 0.84% | +37.5% |
| Q2 2019 | $17,057,000 | +247.3% | 1,137,142 | +306.1% | 0.61% | +226.1% |
| Q1 2019 | $4,911,000 | +18.3% | 280,000 | 0.0% | 0.19% | +13.3% |
| Q4 2018 | $4,150,000 | -39.8% | 280,000 | 0.0% | 0.17% | -32.8% |
| Q3 2018 | $6,894,000 | +25.4% | 280,000 | 0.0% | 0.25% | +28.0% |
| Q2 2018 | $5,496,000 | -26.7% | 280,000 | -30.0% | 0.19% | -25.8% |
| Q1 2018 | $7,500,000 | – | 400,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |